Literature DB >> 3128274

Tumour necrosis factor (cachectin) induces phospholipase A2 activity and synthesis of a phospholipase A2-activating protein in endothelial cells.

M A Clark1, M J Chen, S T Crooke, J S Bomalaski.   

Abstract

Tumour necrosis factor (TNF) is an important mediator of endotoxin-induced vascular collapse and other inflammatory reactions. Eicosanoids have been implicated in the pathogeensis of these responses. In order to explore further the potential interactions between TNF and eicosanoid metabolism in eliciting vascular responses, we studied the effects of TNF on the bovine endothelial cell line CPAE. TNF induced cellular retraction observed by light microscope. This morphological change was monitored by the passage of iodinated protein A between adjacent cells and by release of [3H]arachidonic acid metabolites from cells. Both the morphological and functional responses were abrogated by inhibition of eicosanoid synthesis with BW755c. The release of [3H]arachidonic acid metabolites appeared to be mediated by a transient increase in phospholipase A2 activity. Phospholipase C activity was not affected by TNF. The maximal increase in phospholipase A2 activity occurred at 5 min following the addition of TNF. Phospholipase A2 activation, [3H]arachidonic acid-metabolite synthesis and passage of iodinated protein A, required both RNA and protein synthesis and were associated with an increase in the synthesis of a recently described phospholipase A2-activating protein. The Bordetella pertussis toxin, islet-activating protein, also inhibited the increase in phospholipase A2 activity, the release of [3H]arachidonic acid metabolites and the passage of iodinated protein A, suggesting that the TNF receptor-ligand interaction resulting in cellular retraction, phospholipase A2 activation and eicosanoid synthesis, is coupled through the Ni guanine nucleotide regulatory protein in these cells.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3128274      PMCID: PMC1148824          DOI: 10.1042/bj2500125

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  33 in total

1.  Islet-activating protein inhibits leukotriene D4- and leukotriene C4- but not bradykinin- or calcium ionophore-induced prostacyclin synthesis in bovine endothelial cells.

Authors:  M A Clark; T M Conway; C F Bennett; S T Crooke; J M Stadel
Journal:  Proc Natl Acad Sci U S A       Date:  1986-10       Impact factor: 11.205

Review 2.  Cachectin and tumour necrosis factor as two sides of the same biological coin.

Authors:  B Beutler; A Cerami
Journal:  Nature       Date:  1986 Apr 17-23       Impact factor: 49.962

3.  Leukotriene D4 treatment of bovine aortic endothelial cells and murine smooth muscle cells in culture results in an increase in phospholipase A2 activity.

Authors:  M A Clark; D Littlejohn; T M Conway; S Mong; S Steiner; S T Crooke
Journal:  J Biol Chem       Date:  1986-08-15       Impact factor: 5.157

4.  Cachectin/TNF as well as interleukin-1 induces prostacyclin synthesis in cultured vascular endothelial cells.

Authors:  M Kawakami; S Ishibashi; H Ogawa; T Murase; F Takaku; S Shibata
Journal:  Biochem Biophys Res Commun       Date:  1986-12-15       Impact factor: 3.575

5.  Tumor necrosis factor type alpha stimulates human endothelial cells to produce granulocyte/macrophage colony-stimulating factor.

Authors:  V C Broudy; K Kaushansky; G M Segal; J M Harlan; J W Adamson
Journal:  Proc Natl Acad Sci U S A       Date:  1986-10       Impact factor: 11.205

6.  Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: characterization and comparison with the actions of interleukin 1.

Authors:  M P Bevilacqua; J S Pober; G R Majeau; W Fiers; R S Cotran; M A Gimbrone
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

7.  Actions of tumor necrosis factor on cultured vascular endothelial cells: morphologic modulation, growth inhibition, and cytotoxicity.

Authors:  N Sato; T Goto; K Haranaka; N Satomi; H Nariuchi; Y Mano-Hirano; Y Sawasaki
Journal:  J Natl Cancer Inst       Date:  1986-06       Impact factor: 13.506

8.  Enhanced phospholipase activity in peripheral blood monocytes from patients with rheumatoid arthritis.

Authors:  J S Bomalaski; M A Clark; R B Zurier
Journal:  Arthritis Rheum       Date:  1986-03

9.  Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1.

Authors:  C A Dinarello; J G Cannon; S M Wolff; H A Bernheim; B Beutler; A Cerami; I S Figari; M A Palladino; J V O'Connor
Journal:  J Exp Med       Date:  1986-06-01       Impact factor: 14.307

10.  Histamine type I receptor occupancy increases endothelial cytosolic calcium, reduces F-actin, and promotes albumin diffusion across cultured endothelial monolayers.

Authors:  D Rotrosen; J I Gallin
Journal:  J Cell Biol       Date:  1986-12       Impact factor: 10.539

View more
  45 in total

1.  Tumour necrosis factor-alpha stimulates invasiveness of T-cell hybridomas and cytotoxic T-cell clones by a pertussis toxin-insensitive mechanism.

Authors:  G La Rivière; J W Klein Gebbinck; C A Schipper; E Roos
Journal:  Immunology       Date:  1992-02       Impact factor: 7.397

2.  "Tissue" transglutaminase is specifically expressed in neonatal rat liver cells undergoing apoptosis upon epidermal growth factor-stimulation.

Authors:  M Piacentini; F Autuori; L Dini; M G Farrace; L Ghibelli; L Piredda; L Fesus
Journal:  Cell Tissue Res       Date:  1991-02       Impact factor: 5.249

3.  Rheumatoid arthritis synovial fluid phospholipase A2 activating protein (PLAP) stimulates human neutrophil degranulation and superoxide ion production.

Authors:  J S Bomalaski; D Baker; N V Resurreccion; M A Clark
Journal:  Agents Actions       Date:  1989-06

4.  Production of leukotriene B4 in parenchymal and sinusoidal cells of the liver in rats treated simultaneously with D-galactosamine and endotoxin.

Authors:  Y Shiratori; H Moriwaki; Y Muto; H Onishi; M Kato; F Asano
Journal:  Gastroenterol Jpn       Date:  1989-12

Review 5.  Cytidine 5'-diphosphocholine (CDP-choline) in stroke and other CNS disorders.

Authors:  Rao Muralikrishna Adibhatla; J F Hatcher
Journal:  Neurochem Res       Date:  2005-01       Impact factor: 3.996

6.  Tumor necrosis factor-alpha-mediated decrease in glutathione increases the sensitivity of pulmonary vascular endothelial cells to H2O2.

Authors:  Y Ishii; C A Partridge; P J Del Vecchio; A B Malik
Journal:  J Clin Invest       Date:  1992-03       Impact factor: 14.808

7.  Human cytomegalovirus-induced immunosuppression. Relationship to tumor necrosis factor-dependent release of arachidonic acid and prostaglandin E2 in human monocytes.

Authors:  M A Nokta; M I Hassan; K Loesch; R B Pollard
Journal:  J Clin Invest       Date:  1996-06-01       Impact factor: 14.808

8.  Biphasic regulation by dexamethasone of IL-1- and LPS-stimulated endothelial prostacyclin production.

Authors:  G Prajgrod; A Danon
Journal:  Agents Actions       Date:  1992-03

9.  Studies on the expression of the TNF alpha receptors (p55 and p75) and their relative contributions to prostanoid production and glycolytic rate by rheumatoid synovial fibroblasts in vitro.

Authors:  D J Taylor
Journal:  Rheumatol Int       Date:  1993       Impact factor: 2.631

10.  The role of inflammatory mediators in the pathogenesis of otitis media and sequelae.

Authors:  Steven K Juhn; Min-Kyo Jung; Mark D Hoffman; Brian R Drew; Diego A Preciado; Nicholas J Sausen; Timothy T K Jung; Bo Hyung Kim; Sang-Yoo Park; Jizhen Lin; Frank G Ondrey; David R Mains; Tina Huang
Journal:  Clin Exp Otorhinolaryngol       Date:  2008-09-30       Impact factor: 3.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.